the impact of a video cell phone reminder system on glycemic control in patients with diabetes mellitus

Conditions: Diabetes Mellitus

Summary: the purpose of the study is to determine whether having a video cell phone that gives daily reminders over a 6-month period to check blood surgery and take your diabetes medications can improve your diabetes control during that time and if that benefit lasts for up to 1 year.

the purpose of this study is to determine if a cell phone video reminder system will improve compliance and glycemic control in patients with diabetes mellitus when compared with standard of care. we plan to partner with affinity network, inc., a local minority-owned small business, to provide broadband-enabled cell phone service to patients with diabetes mellitus. their intelacare™ system will host the content and transmit it to the phones on a personalized schedule. this will be a prospective, randomized, controlled trial comparing patients with diabetes mellitus who receive daily video reminders via cell phone to take their medications and check their blood glucose with patients who are just given a cell phone without daily reminders. the primary endpoint will be improvement of glycemic control as measured by glycosylated hemoglobin (a1c). the secondary endpoints will compare mean daily glucose levels, the number of both hypoglycemic and hyperglycemic events, the amount of time spent in target blood glucose, and the perceived level of diabetes-related stress between the two groups. patients in both groups will receive a broad-band enabled cell phone and cell phone service for the duration of the study. patients will be randomized into a "cell phone" group (group a) and a "cell phone plus reminder" group (group b). they will be seen by their provider at least quarterly (or more often as clinically appropriate). blood glucose readings will be downloaded from patients' glucometers at every provider visit (at least quarterly). group b will receive a daily 15-second video from their provider reminding them to take their medication and to test their blood sugar and an educational "tip-of-the day." these reminders will be personalized and recorded by their provider. during the second 6 months, the patients will be followed by their provider at least quarterly. improvement in glycemic control will be determined by quarterly measurements of a1c and the mean and standard deviation of blood glucose. in addition, the number of home blood glucose tests performed on a weekly basis will be compared. compliance with medication will be determined by pharmacy refill records and pill counts. quality-of-life will be measures using 2 validated instruments at 0, 26 and 52 weeks - the problem areas in diabetes (paid), which is a diabetes-related quality of life questionnaire and the sf-8, which is a general quality of life questionnaire for people with chronic disease.

Eligibility criteria:
inclusion criteria: * age 18 or greater * a1c greater than 8% * ability to use a cell phone and glucose meter * ability to understand english * on oral therapy and/or insulin exclusion criteria: * under age 18 * non-english speaking * females who are pregnant, lactating, planning to become pregnant, or without a safe contraceptive method * a1c less than 8% * use of glucocorticoids, amphetamines, anabolic, or weight-reducing agents during the course of the study

Keywords: diabetes mellitus